9,746 results

#161239

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#161229

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#165577

Site-specific DNA methyltransferase; protects DNA from cleavage by XbaI

Drew Endy, Jennifer Molloy, FreeGenes Project

Aug. 24, 2021

Industry, Academic Institutions, and Nonprofits

#165561

Bifunctional DNA glycosylase with DNA N-glycosylase and AP lyase activities; The N-glycosylase activity releases damaged pyrimidines, including thymine glycol and uracil glycol. The AP lyase activity cleaves DNA phosphodiester backbone at AP sites via beta and delta-elimination, creating a 1 nucleotide DNA gap with 5' and 3' phosphate termini.

Drew Endy, Jennifer Molloy, FreeGenes Project

Aug. 16, 2021

Industry, Academic Institutions, and Nonprofits

#165541

Formamidopyrimidine DNA Glycosylase; Bifunctional DNA glycosylase with DNA N-glycosylase and AP lyase activities

Drew Endy, Jennifer Molloy, FreeGenes Project

Aug. 9, 2021

Industry, Academic Institutions, and Nonprofits

#165523

DNA polymerase; lacks 3' to 5' exonuclease activity.

Drew Endy, Jennifer Molloy, FreeGenes Project

Aug. 4, 2021

Industry, Academic Institutions, and Nonprofits

#165518

Site-specific DNA methyltransferase; protects DNA from cleavage by NotI

Drew Endy, Jennifer Molloy, FreeGenes Project

July 29, 2021

Industry, Academic Institutions, and Nonprofits

#170670

Mammalian Expression Plasmid of Anti-cytochrome c, 1D3 HC (Human)

Ronald Jemmerson, Rafel Radi

Tomasina et al Proc Natl Acad Sci U S A. 2022 Nov 22;11

July 12, 2021

Industry, Academic Institutions, and Nonprofits

#161211

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161213

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161219

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161196

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161198

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161201

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161204

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161182

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161183

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161185

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161186

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits

#161187

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

June 21, 2021

Industry, Academic Institutions, and Nonprofits